Bingbing Qiu

Area of research

Pathology and Forensic Medicine · Oncology

Research interest

Research focused on Hepatocellular carcinoma and Cancer research, with related work in Everolimus, Chemokine receptor, Chemokine. Notable publications include 'High interstitial fluid pressure enhances USP1-dependent KIF11 protein stability to promote hepatocellular carcinoma progression', 'The Value of Chemokine and Chemokine Receptors in Diagnosis, Prognosis, and Immunotherapy of Hepatocellular Carcinoma', and 'Enhanced Antipediatric Sarcoma Effect of Everolimus with Secukinumab by Targeting IL17A'.

h-index

—

citations

works

NIH funding

—

primary concept

—

✉ Find email ↗

Recent publications

High interstitial fluid pressure enhances USP1-dependent KIF11 protein stability to promote hepatocellular carcinoma progression

Journal of Translational Medicine 2025cited by 10position: middledoi

The Value of Chemokine and Chemokine Receptors in Diagnosis, Prognosis, and Immunotherapy of Hepatocellular Carcinoma

Cancer Management and Research 2024cited by 3position: middledoi

Enhanced Antipediatric Sarcoma Effect of Everolimus with Secukinumab by Targeting IL17A

Molecular Cancer Therapeutics 2024cited by 2position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Pathology and Forensic Medicine · Oncology →